If you need more lookups,
subscriptions start at $34 USD/month.
Andree Blaukat Location
Germany
Andree Blaukat Work
CEO @ (November 2022 - Present)
Senior Advisor @ (November 2022 - Present)
Senior Vice President - Translational Innovation Platform Oncology and Immuno-Oncology @ (October 2020 - October 2022)
Senior Vice President - Translational Innovation Platform Oncology @ (January 2013 - October 2020)
Head Oncology Platform @ (January 2012 - December 2012)
Senior Director Therapeutic Area Oncology @ (May 2007 - January 2012)
Head Oncology Research Darmstadt @ (January 2007 - April 2007)
Group Leader Receptor Pharmacology and Biomarker Research, Oncology Research @ (October 2004 - December 2006)
Lab Head Oncology Research @ (June 2002 - September 2004)
Junior Group Leader and Lecturer, Institute of Pharmacology @ (June 2000 - May 2002)
Postdoc @ (October 1997 - May 2000)
Andree Blaukat Education
University Mainz & Technical University Darmstadt
Dr.-Ing. (Biochemistry)
1994-1997
Technische Universität Darmstadt
Dipl.-Ing. (Chemistry)
1988-1994
Andree Blaukat Skills
Ingenieurwissenschaften
Chemie
Biochemie
Biowissenschaften
Pharmakologie
Forschung
Lehre
Pharmaforschung
Krebsforschung
Translationale Forschung
Onkologie
Pharmaindustrie
Arzneimittelentwicklung
Personalführung
Budgetmanagement
Veränderungsmanagement
Innovationsmanagement
Projektportfoliomanagement
Strategisches Management
Projektportfoliomanageme
Data Analysis
Strategic Planning
Business Strategy
Andree Blaukat Summary
Andree Blaukat, based in Germany, is currently a CEO at Tessellate BIO. Andree Blaukat brings experience from previous roles at BGV (BioGeneration Ventures) and Healthcare Business of Merck. Andree Blaukat holds a 1994 - 1997 Dr.-Ing. in Biochemistry @ University Mainz & Technical University Darmstadt. With a robust skill set that includes Ingenieurwissenschaften, Chemie, Biochemie, Biowissenschaften, Pharmakologie and more. Andree Blaukat has 1 emails on RocketReach.
Looking for a different Andree Blaukat?
Find contact details for 700 million professionals.